(Q83002620)
Statements
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine? (English)
S Thépot
O Beyne-Rauzy
S Ame
F Isnard
F Dreyfus
C Salanoubat
A L Taksin
Y Chelgoum
C Berthon
J V Malfuson
L Legros
N Vey
P Turlure
C Gardin
S Boehrer
L Ades
P Fenaux
Groupe Francophone des Myelodysplasies (GFM)
15 December 2011